Biopsy as well as FibroTest/Fibrosure is suboptimal for discriminating intermediate fibrosis stages in patients with chronic hepatitis B
Am J Gastroenterol
.
2014 Aug;109(8):1287-8.
doi: 10.1038/ajg.2014.137.
Authors
Mona Munteanu
1
,
Marion Houot
1
,
Yen Ngo
1
,
Thierry Poynard
1
Affiliation
1
BioPredictive, Paris, France.
PMID:
25091245
DOI:
10.1038/ajg.2014.137
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers / blood*
Hepatitis B, Chronic / complications*
Humans
Liver / pathology*
Liver Cirrhosis / diagnosis*
Liver Function Tests*
Substances
Biomarkers